These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 20635761)
21. Facilitated percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: results from the prematurely terminated ADdressing the Value of facilitated ANgioplasty after Combination therapy or Eptifibatide monotherapy in acute Myocardial Infarction (ADVANCE MI) trial. ADVANCE MI Investigators Am Heart J; 2005 Jul; 150(1):116-22. PubMed ID: 16084157 [TBL] [Abstract][Full Text] [Related]
23. Tenecteplase: new preparation. Another thrombolytic agent for myocardial infarction: a slightly simpler treatment. Prescrire Int; 2002 Jun; 11(59):83-4. PubMed ID: 12068843 [TBL] [Abstract][Full Text] [Related]
24. "Tenecteplase--the best among the equals.". Saran RK; Sethi R; Nagori M Indian Heart J; 2009; 61(5):454-8. PubMed ID: 20635761 [TBL] [Abstract][Full Text] [Related]
25. Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction. Melandri G; Vagnarelli F; Calabrese D; Semprini F; Nanni S; Branzi A Vasc Health Risk Manag; 2009; 5(1):249-56. PubMed ID: 19436656 [TBL] [Abstract][Full Text] [Related]
26. Tenecteplase: a review of its pharmacology and therapeutic efficacy in patients with acute myocardial infarction. Dunn CJ; Goa KL Am J Cardiovasc Drugs; 2001; 1(1):51-66. PubMed ID: 14728052 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction. Tanswell P; Modi N; Combs D; Danays T Clin Pharmacokinet; 2002; 41(15):1229-45. PubMed ID: 12452736 [TBL] [Abstract][Full Text] [Related]
33. A review of available fibrin-specific thrombolytic agents used in acute myocardial infarction. Tsikouris JP; Tsikouris AP Pharmacotherapy; 2001 Feb; 21(2):207-17. PubMed ID: 11213858 [TBL] [Abstract][Full Text] [Related]
34. Spotlight on reteplase in thrombotic occlusive disorders. Simpson D; Siddiqui MA; Scott LJ; Hilleman DE BioDrugs; 2007; 21(1):65-8. PubMed ID: 17263591 [TBL] [Abstract][Full Text] [Related]